ProcartaPlex™ Human Growth Factor Panel, 11plex
ProcartaPlex™ Human Growth Factor Panel, 11plex
Invitrogen™

ProcartaPlex™ Human Growth Factor Panel, 11plex

El panel ProcartaPlex Chemokine 11-Plex de factor de crecimiento humano permite la investigación de la respuesta gracias al análisis deMás información
Have Questions?
Número de catálogoCantidad
EPX110-12170-90196 pruebas
Número de catálogo EPX110-12170-901
Precio (MXN)
-
Cantidad:
96 pruebas
El panel ProcartaPlex Chemokine 11-Plex de factor de crecimiento humano permite la investigación de la respuesta gracias al análisis de 11 proteínas diana en un solo pocillo, mediante la tecnología Luminex xMAP. Este panel es un módulo del panel 1 ProcartaPlex 45-Plex de citocina/quimiocina/factor de crecimiento (n.º de ref. EPX450-12171-901). Este kit es totalmente combinable con los otros módulos o ensayos individuales simples correspondientes a los objetivos del panel de 45 plex.

Los paneles preconfigurados ProcartaPlex se han probado exhaustivamente para determinar la capacidad combinatoria, la interferencia y la reactividad cruzada de los analitos con el fin de proporcionar el mayor nivel de validación y precisión. Todos los paneles ProcartaPlex se suministran con los reactivos necesarios para realizar el ensayo.

Los paneles multiplex ProcartaPlex están disponibles en múltiples formatos en seis especies (humano, ratón, rata, primate no humano, porcino y canino). Visite nuestra página de inmunoensayos ProcartaPlex para obtener más información y consultar los productos disponibles.

Lista de objetivos [región de gránulos]: BDNF [57], EGF [56], FGF-2 [75], HGF [46], LIF [15], NGF beta [55], PDGF-BB [77], PlGF-1 [29], SCF [39], VEGF-A [78], VEGF-D [53]

Acerca de los ensayos ProcartaPlex para la plataforma Luminex
Los inmunoensayos ProcartaPlex están basados en los principios de un ELISA tipo sándwich. Utilizan dos anticuerpos específicos que se enlazan a diferentes epítopos de una proteína para cuantificar todas las proteínas diana de forma simultánea, mediante el uso de un instrumento Luminex. Para los ensayos multiplex ProcartaPlex se requieren tan solo 25 µl de plasma o suero, o 50 µl de sobrenadante del cultivo celular, y solo se necesitan cuatro horas para obtener los resultados analizados.

Las características incluyen:
• Resultados reproducibles y fiables: validados como panel según el estándar más alto del sector, incluidas las pruebas de combinación de proteínas diana y reactividad cruzada
• Más resultados por muestra: permite medir múltiples proteínas diana simultáneamente en una única muestra de 25–50 µL
• Tecnología Luminex consolidada: plataforma de multiplexing de referencia para detección y cuantificación de proteínas

Los ensayos ProcartaPlex utilizan la tecnología Luminex xMAP (método multianálito) para la detección y cuantificación simultáneas de hasta 65 proteínas diana en una única muestra de 25–50 µL de plasma, suero, sobrenadantes del cultivo celular y otros fluidos corporales.

Las microesferas de Luminex del ensayo de ProcartaPlex se tiñen internamente con proporciones precisas de fluoróforos rojos e infrarrojos para crear firmas específicas que pueden ser identificadas por los sistemas de detección Luminex xMAP (por ejemplo, Luminex 200, FLEXMAP 3D y MAGPIX). El ensayo ProcartaPlex, similar a un ELISA tipo sándwich, utiliza pares de anticuerpos emparejados para identificar la proteína de interés. En un ensayo multiplex, cada gránulo espectralmente único se etiqueta con anticuerpos específicos para una sola proteína diana, y las proteínas vinculadas se identifican con anticuerpos biotinilados y estreptavidina-R-ficoeritrina (RPE). La conjugación de anticuerpos específicos de proteínas en un gránulo distinto permite el análisis de varios elementos diana en un solo pocillo.

La diferencia más significativa entre un ensayo ProcartaPlex y uno ELISA es que el anticuerpo de captura del ensayo ProcartaPlex se conjuga en un gránulo y no se adsorbe en el pocillo de la microplaca, por lo que los reactivos del ensayo ProcartaPlex flotan en la solución. Para la detección, el instrumento Luminex 200, por ejemplo, contiene dos láseres, uno para distinguir la firma espectral de cada partícula y el segundo para cuantificar la cantidad de fluorescencia RPE, que es proporcional a la cantidad de proteína presente en la muestra. Los ensayos multiplex ProcartaPlex pueden determinar el perfil de más proteínas diana con mucha menos muestra en el mismo tiempo que se tarda en realizar un ELISA tipo sándwich tradicional.

Los paneles multiplex ProcartaPlex están disponibles en múltiples formatos en seis especies (humano, ratón, rata, primate no humano, porcino y canino). Visite thermofisher.com/procartaplex para obtener más información y consultar los productos disponibles.

Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.

Especificaciones
Intervalo del ensayoVer certificado de análisis
Sensibilidad del ensayoMenos del 15 %
Para utilizar con (equipo)Instrumentos Luminex™
FormatoKit multiplex
Línea de productosProcartaPlex
Tipo de muestraSobrenadantes de cultivo celular, suero y plasma, Plasma, Cell Culture Supernatants
Volumen de muestraSuero, plasma: 25 μl; CCS: 50 μl
Condiciones de envíoWet Ice
CombinabilityCombinable
Tipo de productoPanel de multiplexado
Cantidad96 pruebas
Research AreaImmunology, Growth Factors
EspecieHumano
Unit SizeEach
Contenido y almacenamiento
• 2 viales de mezcla estándar humana C (liofilizada)
• 1 vial de mezcla de gránulos de captura (1x)
• 1 vial de mezcla de anticuerpos de detección biotinilados (50x)
• 1 frasco de tampón de lectura (1x)
• 1 frasco de tampón de lavado (10x)
• 1 frasco de estreptavidina-PE (1x)
• 1 frasco de tampón de ensayo universal (1x)
• 1 frasco de diluyente de anticuerpos de detección (1x)
• Tira de 8 tubos
• Película adhesiva
• Placa de 96 pocillos de fondo plano, negra

Almacenar a 2–8 °C.

Preguntas frecuentes

What is the size of the Luminex beads you currently use?

The beads used in our Luminex instrument-compatible ProcartaPlex and QuantiGene Plex assays are 6.5 micron superparamagnetic beads.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

I am interested in performing Luminex assays using BioSource kits, and I have a Luminex xMAP system. Besides the kits and system, what other reagents and equipment will I need?

The following is a list of general lab supplies that are required for running BioSource immunoassays on the Luminex xMAP system:
1) Sonicating water bath
2) Orbital shaker
3) Vortexer
4) Repeating and/or multi-channel pipetter (not required, but recommended)
5) Calibrated adjustable precision pipettes, with disposable plastic tips
6) Glass/plastic tubes and racks for preparing reagents
7) Graduated cylinder and container for preparing wash solution
8) Aluminum foil
9) Deionized or distilled water.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Do the Luminex beads require special care in handling?

The Luminex beads should be protected from light because they are susceptible to photobleaching. We recommend protecting the beads by keeping containers covered with aluminum foil during all incubation steps, and exercising care during handling. The beads should not be frozen, subjected to excessive heat, or exposed to organic solvents.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Why would the Luminex acquisition software display "Sample Empty" messages during analysis?

(1) The user did not properly aliquot the diluted beads, such that no beads were actually added to the wells (make sure that the bead concentrates are sonicated and vortexed well, then check the pipet tip to ensure that air bubbles were not drawn up)
(2) The user missed loading diluted beads to some wells, which is likely since the small volume is clear and difficult to visualize in the clear plastic plate (we have now addressed this customer difficulty by coloring each of the Buffer Reagent Kit components)
(3) The user applied too much vacuum pressure at some point during the wash steps, or allowed the pressure to spike even once, such that the filter membrane tore in a few wells releasing the beads (make sure that the vacuum manifold pressure is kept below 5mm/in Hg, depending on their system -- a good rule of thumb is that it should take a full 3-second count to GENTLY empty the wells of 200uL)
(4) The user did not properly sonicate and vortex the beads prior to dilution, such that the percent of bead aggregation was high and the instrument was unable to find enough single beads to meet the events/bead value designated by the customer (make sure that the Bead Concentrate tube is put into the waterbath all the way to the cap, since the tube is hollow until the top third)
(5) The user lost beads by shaking the plate too aggressively or handling it improperly (make sure that the orbital shaker is set to a speed that allows for maximum vortex in the wells without spillage)
(6) The user exposed the beads to an excess of light during storage or running of the assay, such that some but not all of the beads were photobleached and therefore falling outside the acceptable range for each bead region (make sure that the plate is covered on the top/sides with foil throughout the assay, away from Windows and spotlights, and that the bead component of the kits is stored in the dark)*
(7) There was a clog in the sample needle, such that the instrument was unable to take up enough sample to meet the number of events requested per bead region (suggest that the user follow the manual instructions for dislodging a clog, which include several Back Flush steps and may require removal of the needle for sonication with probe alignment).

* Some of the older Antibody Bead Kits still have clear plastic tops instead of black ones. In cases where customers store kits in lit refrigerators, or keep them open on the lab bench, even a few hours of light exposure is enough to photobleach beads. It is important to note, in general, that higher number bead regions are more susceptible to photobleaching. In order to draw conclusions about the source of the difficulty, we would ask to see the data, specifically the Masterplex QT file, which would enable us to examine the pattern of "Sample Empty" occurrences in addition to the bead counts per well.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

What are the Luminex beads made of?

The beads are made of polystyrene.

Find additional tips, troubleshooting help, and resources within our Protein Assays and Analysis Support Center.

Citations & References (5)

Citations & References
Abstract
Mesenchymal stromal cells isolated from human fetal liver release soluble factors with a potential role in liver tissue repair.
Authors:Chinnici CM, Pietrosi G, Iannolo G, Amico G, Cuscino N, Pagano V, Conaldi PG
Journal:
PubMed ID:30553176
We isolated a population of proliferating cells from cultured human fetal hepatocytes of 16-22 weeks gestational age. The cells shared a similar phenotype to that of mesenchymal stromal cells (MSCs) according to the International Society for Cellular Therapy (ISCT), including plastic adherence, antigen expression profile, and in vitro multilineage differentiation ... More
Development of a 3D angiogenesis model to study tumour - endothelial cell interactions and the effects of anti-angiogenic drugs.
Authors:Amann A, Zwierzina M, Koeck S, Gamerith G, Pechriggl E, Huber JM, Lorenz E, Kelm JM, Hilbe W, Zwierzina H, Kern J
Journal:Sci Rep
PubMed ID:28592821
'The tumour microenvironment and tumour angiogenesis play a critical role in the development and therapy of many cancers, but in vitro models reflecting these circumstances are rare. In this study, we describe the development of a novel tri-culture model, using non-small cell lung cancer (NSCLC) cell lines (A549 and Colo699) ... More
Imetelstat, a telomerase inhibitor, differentially affects normal and malignant megakaryopoiesis.
Authors:Mosoyan G, Kraus T, Ye F, Eng K, Crispino JD, Hoffman R, Iancu-Rubin C
Journal:Leukemia
PubMed ID:28270692
Imetelstat (GRN163L) is a specific telomerase inhibitor that has demonstrated clinical activity in patients with myeloproliferative neoplasms (MPN) and in patients with solid tumors. The antitumor effects were associated with the development of thrombocytopenia, one of the common side effects observed in patients treated with imetelstat. The events underlying these ... More
Development of vascularized nerve scaffold using perfusion-decellularization and recellularization.
Authors:Wüthrich T, Lese I, Haberthür D, Zubler C, Hlushchuk R, Hewer E, Maistriaux L, Gianello P, Lengelé B, Rieben R, Vögelin E, Olariu R, Duisit J, Taddeo A
Journal:Mater Sci Eng C Mater Biol Appl
PubMed ID:32919672
Vascularized nerve grafts (VNG) may offer an advantage in peripheral nerve regeneration by avoiding ischemic damage and central necrosis observed in non-VNG, particularly for the treatment of large and long nerve defects. However, surgical complexity, donor site morbidity and limited nerve availability remain important drawbacks for the clinical use of ... More
A Novel Intravesical Dextrose Injection Improves Lower Urinary Tract Symptoms on Interstitial Cystitis/Bladder Pain Syndrome.
Authors:Chen CL, Kao CC, Yang MH, Fan GY, Cherng JH, Tsao CW, Wu ST, Cha TL, Meng E
Journal:Front Pharmacol
PubMed ID:34975473
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a painful recurrent condition characterized by the discomfort of the bladder, and current treatment options have limited effectiveness. Prolotherapy is a well-known treatment that involves the injection of non-biologic solutions to reduce pain and/or promote proliferation of soft tissue, and dextrose is the most ... More